Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2014
09/18/2014US20140271799 Transdermal administration of fentanyl and analogs thereof
09/18/2014US20140271541 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
09/16/2014US8834849 Medicinal aerosols and methods of delivery thereof
09/09/2014US8828317 Antiseptic compositions, methods and systems
09/04/2014US20140248267 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
09/04/2014US20140248253 Compositions and methods for the treatment of cns injuries
09/03/2014EP2772254A2 Novel Antibacterial Agents
09/02/2014US8822673 Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
09/02/2014US8822499 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/02/2014US8822442 Somatostatin-dopamine chimeric analogs
09/02/2014US8822156 Methods for rapid identification of pathogens in humans and animals
08/2014
08/28/2014US20140243398 Irs modulators
08/28/2014US20140242000 Composition, comprising hydrofluoric acid, for inhibiting dental erosion
08/26/2014US8815823 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/26/2014US8815801 Controlled release composition and method of producing the same
08/26/2014US8815236 Method for treating multiple sclerosis and crohn's disease
08/21/2014US20140234454 Composition for treating aids and associated conditions
08/19/2014US8809516 Therapeutic compositions
08/19/2014US8809294 Method of inhibiting miR-33 using a modified oligonucleotide
08/19/2014US8808765 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
08/19/2014CA2574437C Infusion and injection solution of levodopa
08/19/2014CA2545435C Hydroxy piperidine derivatives to treat gaucher disease
08/14/2014US20140228327 Antimicrobial flush solutions
08/13/2014EP2764865A2 Cancer treatment
08/12/2014US8801847 Microcrystalline cellulose compositions
08/12/2014CA2520392C Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding
08/07/2014US20140221489 Infusion and Injection Solution of Levodopa
08/07/2014US20140221413 Preoperative treatment of post operative pain
08/07/2014US20140221407 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
08/06/2014EP2762140A1 Treatment of solid brain tumours with a rapamycin derivative
08/06/2014CN101670105B 螯合淀粉样蛋白β肽的人源化抗体 Human amyloid β peptide chelating humanized antibody
08/06/2014CN101001631B 利用连续给予雌激素的避孕方案的激素治疗方法 Continuous use of hormone therapy given estrogen contraceptive programs
08/05/2014US8796341 Pharmaceutical compositions providing enhanced drug concentrations
08/05/2014US8795653 Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
08/05/2014CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine
07/2014
07/30/2014CN101869535B 功能香味前体 Function flavor precursors
07/29/2014US8791159 Compound capable of binding S1P receptor and pharmaceutical use thereof
07/29/2014CA2697205C Peptidomimetic protease inhibitors
07/24/2014US20140206750 MODULATION OF APOLIPOPROTEIN (a) EXPRESSION
07/22/2014US8785606 Compositions and methods for promoting neuronal outgrowth
07/22/2014US8785415 Oral formulations of cladribine
07/17/2014US20140200332 Low dose methods for treating disorders in which tnf-alpha activity is detrimental
07/17/2014US20140200183 Treatment of cardiac arrhythmias
07/17/2014US20140199282 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
07/15/2014US8779117 Pharmaceutical compositions comprising 5-azacytidine monohydrate
07/15/2014US8779106 Antibodies to human β-adrenergic receptor kinase
07/15/2014US8778963 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
07/15/2014US8778962 Treatment of solid tumors with rapamycin derivatives
07/15/2014US8778344 Method of treating atopic dermatitis with antibody to zcytor17 ligand
07/15/2014CA2552279C Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
07/15/2014CA2526640C Immunogenic reagents from west nile virus
07/15/2014CA2526398C Human monoclonal antibodies against bacillus anthracis protective antigen
07/10/2014US20140194628 Substituted imidazo ring systems and methods
07/10/2014US20140194519 Antiseptic compositions, methods and systems
07/10/2014US20140194518 Antiseptic compositions, methods and systems
07/10/2014US20140193345 Herbal compositions for the treatment of mucosal lesions
07/10/2014US20140193332 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
07/09/2014CN1795009B 抗-cd33抗体及其用途 Antibodies and their use of anti--cd33
07/08/2014US8772246 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
07/08/2014US8771935 Screening methods for cognitive enhancers
07/08/2014US8771763 Composition for treating aids and associated conditions
07/08/2014US8771675 Probiotic strains for pets
07/08/2014US8771671 Induced activation in dendritic cells
07/08/2014CA2545653C Asymmetrically branched polymer conjugates and microarray assays
07/08/2014CA2520255C Tie-2 modulators and methods of use
07/08/2014CA2519131C Ligands for tgf-beta binding proteins and uses thereof
07/08/2014CA2447180C Herbal compositions for the treatment of mucosal lesions
07/03/2014US20140187772 Pyrazole compounds useful as protein kinase inhibitors
07/03/2014US20140187576 Salt of naphthyridine carboxylic acid derivative
07/03/2014US20140187530 AZA Spiro Alkane Derivatives as Inhibitors of Metalloproteases
07/03/2014US20140187485 Novel receptor nucleic acids and polypeptides
07/01/2014US8765701 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
07/01/2014US8765685 Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)
06/2014
06/25/2014CN101759645B p38抑制剂及它们的使用方法 p38 inhibitors and methods for their use
06/24/2014US8759304 Compositions and methods for increasing telomerase activity
06/24/2014US8758759 Transmucosal administration of aggregated antigens
06/24/2014US8758742 Prebiotic and preservative uses of oil emulsified probiotic encapsulations
06/18/2014CN102526079B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
06/18/2014CN101947306B Treatment of T-cell mediated diseases
06/17/2014US8754201 Therapeutic compositions
06/17/2014CA2564436C Use of chondroitin sulphate e (cs-e ) for the treatment of disease or conditions related to collagen fibril formation.
06/17/2014CA2451740C Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
06/12/2014US20140163051 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocyclical Guanidine, For Cosmetology, Wound Healing, Focal Dystonia and Muscular Spasm- Related Clinical Pathologies
06/10/2014US8748476 Darifenacin for use in the treatment of urgency induced by overactive bladder
06/10/2014US8748463 Histone deacetylase inhibitors and methods of use thereof
06/10/2014US8748171 Cell population enriched for endoderm cells
06/10/2014US8747851 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same
06/10/2014US8747843 Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor
06/05/2014US20140155396 C-Met Modulators and Method of Use
06/05/2014US20140155378 c-Met Modulators and Method of Use
06/05/2014US20140154259 Method for the treatment of inflammatory disorders
06/05/2014US20140154242 Immunoglobulin variants and uses thereof
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
06/04/2014CN103833854A Immunoglobulin variants and uses thereof
06/03/2014US8741880 Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
06/03/2014CA2548149C Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
05/2014
05/29/2014US20140148436 Akt protein kinase inhibitors
05/29/2014US20140148389 Methods for accelerating wound healing by administration of adipokines
05/28/2014CN1840178B 肿瘤特异性动物蛋白 Tumor-specific animal protein
05/27/2014US8735420 Polymorphic forms of naltrexone
1 2 3 4 5 6 7 8 9 10 11 12 ... 295